Lee S Cohen

Array ( [id] => 1524436 [patent_doc_number] => 06353104 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Method for producing high melting point crystals of phenoxypropionic acid derivative' [patent_app_type] => B1 [patent_app_number] => 09/674282 [patent_app_country] => US [patent_app_date] => 2000-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2571 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/353/06353104.pdf [firstpage_image] =>[orig_patent_app_number] => 09674282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1418101 [patent_doc_number] => 06509354 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-21 [patent_title] => '3-arylphenyl sulfide derivative and insecticide and miticide' [patent_app_type] => B1 [patent_app_number] => 09/673633 [patent_app_country] => US [patent_app_date] => 2000-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51776 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 386 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/509/06509354.pdf [firstpage_image] =>[orig_patent_app_number] => 09673633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1328329 [patent_doc_number] => 06599942 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-29 [patent_title] => 'Thyromimetic organic compounds' [patent_app_type] => B1 [patent_app_number] => 09/696502 [patent_app_country] => US [patent_app_date] => 2000-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12352 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599942.pdf [firstpage_image] =>[orig_patent_app_number] => 09696502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1393168 [patent_doc_number] => 06545004 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Methods and compositions utilizing quinazolinones' [patent_app_type] => B1 [patent_app_number] => 09/699047 [patent_app_country] => US [patent_app_date] => 2000-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 92 [patent_no_of_words] => 13477 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/545/06545004.pdf [firstpage_image] =>[orig_patent_app_number] => 09699047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478663 [patent_doc_number] => 06451804 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Heteroalkylamino-substituted bicyclic nitrogen heterocycles' [patent_app_type] => B1 [patent_app_number] => 09/693337 [patent_app_country] => US [patent_app_date] => 2000-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34850 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451804.pdf [firstpage_image] =>[orig_patent_app_number] => 09693337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4269378 [patent_doc_number] => 06306874 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Tyrosine kinase inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/690598 [patent_app_country] => US [patent_app_date] => 2000-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29471 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306874.pdf [firstpage_image] =>[orig_patent_app_number] => 690598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1378017 [patent_doc_number] => 06559143 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-06 [patent_title] => 'Oxabispidine compounds useful in the treatment of cardiac arrhyythmias' [patent_app_type] => B1 [patent_app_number] => 09/688251 [patent_app_country] => US [patent_app_date] => 2000-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33883 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/559/06559143.pdf [firstpage_image] =>[orig_patent_app_number] => 09688251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1425467 [patent_doc_number] => 06503908 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-07 [patent_title] => 'Pharmaceutically active compounds' [patent_app_type] => B1 [patent_app_number] => 09/685160 [patent_app_country] => US [patent_app_date] => 2000-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10494 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 472 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/503/06503908.pdf [firstpage_image] =>[orig_patent_app_number] => 09685160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4371008 [patent_doc_number] => 06288070 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Triazolopurine derivatives, medicinal composition containing the derivatives, adenosine A3 receptor compatibilizing agent, and asthmatic remedy' [patent_app_type] => 1 [patent_app_number] => 9/647613 [patent_app_country] => US [patent_app_date] => 2000-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12957 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288070.pdf [firstpage_image] =>[orig_patent_app_number] => 647613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1543109 [patent_doc_number] => 06372743 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines' [patent_app_type] => B1 [patent_app_number] => 09/676970 [patent_app_country] => US [patent_app_date] => 2000-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39548 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 2051 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372743.pdf [firstpage_image] =>[orig_patent_app_number] => 09676970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1518010 [patent_doc_number] => 06500948 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof' [patent_app_type] => B1 [patent_app_number] => 09/675555 [patent_app_country] => US [patent_app_date] => 2000-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35654 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500948.pdf [firstpage_image] =>[orig_patent_app_number] => 09675555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1581703 [patent_doc_number] => 06423716 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'Nitrogenous heterocyclic compounds' [patent_app_type] => B1 [patent_app_number] => 09/647490 [patent_app_country] => US [patent_app_date] => 2000-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22422 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1976 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423716.pdf [firstpage_image] =>[orig_patent_app_number] => 09647490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1245972 [patent_doc_number] => 06677345 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-13 [patent_title] => 'Cyclin dependent kinase inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/671676 [patent_app_country] => US [patent_app_date] => 2000-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 9801 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 297 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677345.pdf [firstpage_image] =>[orig_patent_app_number] => 09671676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1474970 [patent_doc_number] => 06387893 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Spirotricyclic substituted azacycloalkane derivatives and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/671520 [patent_app_country] => US [patent_app_date] => 2000-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33452 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 993 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387893.pdf [firstpage_image] =>[orig_patent_app_number] => 09671520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4311988 [patent_doc_number] => 06316437 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Spirohydantoin compounds and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/671417 [patent_app_country] => US [patent_app_date] => 2000-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24472 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1493 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316437.pdf [firstpage_image] =>[orig_patent_app_number] => 671417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1596281 [patent_doc_number] => 06492364 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Triazolo and derivatives as chemokine inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/601620 [patent_app_country] => US [patent_app_date] => 2000-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39802 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492364.pdf [firstpage_image] =>[orig_patent_app_number] => 09601620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 682636 [patent_doc_number] => 07081461 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-25 [patent_title] => 'Quinazoline compounds and pharmaceutical compositions containing them' [patent_app_type] => utility [patent_app_number] => 10/088854 [patent_app_country] => US [patent_app_date] => 2000-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29767 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/081/07081461.pdf [firstpage_image] =>[orig_patent_app_number] => 10088854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 658897 [patent_doc_number] => 07105669 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-12 [patent_title] => 'Quinazoline derivatives' [patent_app_type] => utility [patent_app_number] => 10/088852 [patent_app_country] => US [patent_app_date] => 2000-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26399 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105669.pdf [firstpage_image] =>[orig_patent_app_number] => 10088852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 121770 [patent_doc_number] => 07709479 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-05-04 [patent_title] => 'Quinazoline derivatives and their use as pharmaceuticals' [patent_app_type] => utility [patent_app_number] => 10/088814 [patent_app_country] => US [patent_app_date] => 2000-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 101755 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709479.pdf [firstpage_image] =>[orig_patent_app_number] => 10088814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1411504 [patent_doc_number] => 06528499 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Ligands for metabotropic glutamate receptors and inhibitors of NAALADase' [patent_app_type] => B1 [patent_app_number] => 09/662767 [patent_app_country] => US [patent_app_date] => 2000-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 29296 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528499.pdf [firstpage_image] =>[orig_patent_app_number] => 09662767 [rel_patent_id] =>[rel_patent_doc_number] =>)